Botanix Pharmaceuticals Ltd [ASX:BOT] share price and news 2022

Company Description

Botanix Pharmaceuticals Ltd (BOT, formerly Bone Medical Limited) is a clinical stage synthetic cannabinoid company focuses on development of safe and effective topical treatments for serious skin diseases, leveraging the anti-inflammatory, immune modulating and antimicrobial properties of synthetic cannabidiol.

Botanix Pharmaceuticals Ltd belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.botanixpharma.com.

This a small cap company with market cap of 102 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 4.32 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how bot dividend grows in the recent years.

No data